Cholesterol in colorectal cancer: an essential but tumorigenic precursor?

Colorectal cancer (CRC) is one of the most lethal human malignancies, and with the growth of societies and lifestyle changes, the rate of people suffering from it increases yearly. Important factors such as genetics, family history, nutrition, lifestyle, smoking, and alcohol can play a significant r...

Full description

Bibliographic Details
Main Authors: Xing He, Huanrong Lan, Ketao Jin, Fanlong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1276654/full
_version_ 1797639793989910528
author Xing He
Huanrong Lan
Ketao Jin
Fanlong Liu
author_facet Xing He
Huanrong Lan
Ketao Jin
Fanlong Liu
author_sort Xing He
collection DOAJ
description Colorectal cancer (CRC) is one of the most lethal human malignancies, and with the growth of societies and lifestyle changes, the rate of people suffering from it increases yearly. Important factors such as genetics, family history, nutrition, lifestyle, smoking, and alcohol can play a significant role in increasing susceptibility to this cancer. On the other hand, the metabolism of several macromolecules is also involved in the fate of tumors and immune cells. The evidence discloses that cholesterol and its metabolism can play a role in the pathogenesis of several cancers because there appears to be an association between cholesterol levels and CRC, and cholesterol-lowering drugs may reduce the risk. Furthermore, changes or mutations of some involved genes in cholesterol metabolism, such as CYP7A1 as well as signaling pathways, such as mitogen-activated protein kinase (MAPK), can play a role in CRC pathogenesis. This review summarized and discussed the role of cholesterol in the pathogenesis of CRC as well as available cholesterol-related therapeutic approaches in CRC.
first_indexed 2024-03-11T13:22:17Z
format Article
id doaj.art-437d793daf1641309406b492b69fc8ad
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-11T13:22:17Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-437d793daf1641309406b492b69fc8ad2023-11-03T10:08:52ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-11-011310.3389/fonc.2023.12766541276654Cholesterol in colorectal cancer: an essential but tumorigenic precursor?Xing He0Huanrong Lan1Ketao Jin2Fanlong Liu3Department of Gastroenterology, Jinhua Wenrong Hospital, Jinhua, Zhejiang, ChinaDepartment of Surgical Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, ChinaDepartment of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, ChinaDepartment of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaColorectal cancer (CRC) is one of the most lethal human malignancies, and with the growth of societies and lifestyle changes, the rate of people suffering from it increases yearly. Important factors such as genetics, family history, nutrition, lifestyle, smoking, and alcohol can play a significant role in increasing susceptibility to this cancer. On the other hand, the metabolism of several macromolecules is also involved in the fate of tumors and immune cells. The evidence discloses that cholesterol and its metabolism can play a role in the pathogenesis of several cancers because there appears to be an association between cholesterol levels and CRC, and cholesterol-lowering drugs may reduce the risk. Furthermore, changes or mutations of some involved genes in cholesterol metabolism, such as CYP7A1 as well as signaling pathways, such as mitogen-activated protein kinase (MAPK), can play a role in CRC pathogenesis. This review summarized and discussed the role of cholesterol in the pathogenesis of CRC as well as available cholesterol-related therapeutic approaches in CRC.https://www.frontiersin.org/articles/10.3389/fonc.2023.1276654/fullcholesterolmetabolismcolorectal cancertumorigenictherapeutic approaches
spellingShingle Xing He
Huanrong Lan
Ketao Jin
Fanlong Liu
Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
Frontiers in Oncology
cholesterol
metabolism
colorectal cancer
tumorigenic
therapeutic approaches
title Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
title_full Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
title_fullStr Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
title_full_unstemmed Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
title_short Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
title_sort cholesterol in colorectal cancer an essential but tumorigenic precursor
topic cholesterol
metabolism
colorectal cancer
tumorigenic
therapeutic approaches
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1276654/full
work_keys_str_mv AT xinghe cholesterolincolorectalcanceranessentialbuttumorigenicprecursor
AT huanronglan cholesterolincolorectalcanceranessentialbuttumorigenicprecursor
AT ketaojin cholesterolincolorectalcanceranessentialbuttumorigenicprecursor
AT fanlongliu cholesterolincolorectalcanceranessentialbuttumorigenicprecursor